A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Sorafenib and RAD001 Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow
- Status
- TERMINATED
- Phase
- PHASE2
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)
- Status
- TERMINATED
- Phase
- PHASE2